Many phenotypic traits that are unique to the human lineage are likely to have resulted from selective pressures on our genome and the unique demographic history since our divergence from the Pan lineage approximately 6 million years ago
. A fundamental question that relates to the origin of our species is which genomic sequences contributed to the unique evolutionary trajectory taken by the human lineage. With rapid advances in genomic technologies facilitating the comparison of numerous genomes within and between species, we are in an unprecedented era of advancement in comparative genomics. With the availability of draft genomes for nine primate species, including all of the 'great apes' (namely, chimpanzees, bonobos, gorillas and orangutans), and the ability to sequence the genomes of multiple individuals rapidly within each species, we have never been in a better position to evaluate what genetic changes contributed towards making us human.
A major goal of studies that identify human-lineagespecific (HLS) genomic changes is to correlate genotype with phenotype; however, this task also remains most formidable. As direct human experimentation is not possible, researchers have historically relied on naturally occurring variation and disease to understand HLS implications. A further limitation is the comparatively limited information about non-human primate phenotypes. This type of observational reliance frequently makes particular changes difficult to interpret. Although variation and disease are still heavily relied on, emergent technologies, such as heterologous expression of human regulatory regions in mice 1, 2 , are allowing for evolutionary hypotheses to be tested in ways that were previously not possible. Work in this field has substantially advanced in recent years: the number of gene-to-phenotype candidates has more than doubled since the topic was last covered in two related reviews 3, 4 . This article discusses current knowledge of the genetic and genomic changes that make Homo sapiens different from other primates and puts particular emphasis on recent advancements. We explore genetic changes that may have contributed to human-specific traits, and where applicable we look at the hypothesized evolutionary pressures, such as accelerated evolution (BOX 2) and positive selection, that underlie these changes in human characteristics. We examine HLS genomic changes with a brief look at the technologies that made these discoveries possible and explore a representative group of HLS gene changes along with their associated phenotypes. We then address the growing number of HLS genetic and genomic changes connected to disease, including the correlation between complex loci and multiple disease associations. We conclude with a look at the future challenges in compiling a comprehensive list of HLS changes and their associated traits.
Uniquely human genome changes
The ability to identify genomic changes that are unique to humans depends on the definition of HLS events. In addition to the genome sequence of H. sapiens, there are two ancient hominin lineages -Neanderthals 5 and Denisovans 6 -for which draft genome sequences are currently available. As these two genome sequences are far less accurate and complete than the human assembly, this Review does not rely on them unless the ancient hominin sequencing data for a particular sequence is of a high quality. Our working definition of HLS therefore requires that changes found in the H. sapiens genome be uniquely different from those found in other extant primates. As this Review requires that the changes be well established as being HLS and that they be based on multiple out-group comparisons, it excludes studies reporting on human and chimpanzee differences alone.
Identification of HLS genomic changes can be complicated by several factors that can potentially occlude accurate comparisons of gene and genomic sequences. Gene annotation is often imprecise and can change between different genome builds, making it difficult to determine whether a change is real or whether it represents computational and/or assembly error. The sample size of sequenced individuals can also be an impediment as an apparent HLS change may be polymorphic in only the human population. In addition, the lack of sufficient individuals from the other sequenced primates can make the ancestral state difficult to determine. This is exacerbated by the fact that, with the possible exception of bonobos (Pan paniscus), all great ape species harbour far more sequence diversity than humans 7 . Finally, it is important to have an effective number of primate outgroups to determine HLS status. For example, comparison of gene copy number changes between humans and the great apes found that 57% of the genes that are increased in copy number in humans versus chimpanzees are not HLS 8 . With these criteria defined, we discuss examples of HLS genomic changes below.
Box 1 | Examples of human-lineage-specific traits and potential forces shaping them
Human-lineage-specific (HLS) traits are phenotypes of the human lineage that arose after the split from the Pan lineage. A substantial number of forces are likely to have contributed to the development and maintenance of these traits, and several examples are listed here. Plausible forces commonly discussed are macro-and micro-level climate changes that occurred frequently over the course of human evolution 106 and that may have selected for rapid HLS changes to survive novel climatic challenges. Although an enhanced cognitive capacity would clearly be beneficial in dealing with such extreme and abrupt environmental changes, other important HLS phenotypic changes were also occurring. For example, anatomical and physiological changes associated with endurance running, such as HLS changes in the musculoskeletal system and in energy use and metabolism may have allowed novel hunting practices, such as persistence hunting, to emerge. These in turn may have allowed the energetic benefits of meat to be increasingly incorporated into the human dietary regimen 10, 75, 107 . An incomplete but representative list of traits identified as unique to the human lineage is shown in the table along with possible selective advantages 10, 75, [107] [108] [109] [110] . A more complete list can be found in the Matrix of Comparative Anthropogeny
.
Example of phenotypic feature
Human-lineage-specific trait Possible evolutionary advantages
Brain growth trajectory
Prolonged postnatal brain growth and delayed myelinization period; enhanced cognition Array-based comparative genomic hybridization (Array CGH). A microarraybased method for detecting copy number variation in the genome.
Large-scale changes. Large-scale genomic differences between humans and our closest primate relatives have been noted since the 1970s, when chromosomes were examined using chromatin-stained banding techniques 9 . Given technological limitations, observable differences were restricted to the detection of: a change in the haploid number from 24 to 23 chromosomes owing to the fusion of two ancestral ape chromosomes, resulting in humans having one large chromosome 2; the addition of human-specific constitutive heterochromatic C bands on chromosomes 1, 9, 16 and Y; and humanspecific pericentric inversions on chromosomes 1 and 18 (REF. 9 ). Although no conclusive evidence has as of yet directly linked these cytogenetically visible events to HLS traits, the genomic regions at which these events took place tend to be hotbeds of recent gene duplication, harbouring many unique human-specific genes and copy number variations (CNVs) 8, 10 
. This suggests that selection for these novel genes drove the changes to fixation, although drift cannot be formally excluded as an additional factor. Timing for these events continues to be of interest, with a recent paper based on segmental duplications in chimpanzees and gorillas estimating that the chromosome 2 fusion event occurred ~4-5 million years ago 11 . In the late 1980s, application of fluorescent in situ hybridization (FISH) to banded chromosomes and its further use in FISH chromosome painting in the 1990s permitted the evaluation of large-scale structural changes between humans and great apes that were not visible with conventional banding techniques 12, 13 . More recently, these studies were aided by interspecies bacterial artificial chromosome (BAC)-based array-based comparative genomic hybridization (array CGH) experiments, which identified over 60 HLS segmental duplications greater than 65 kb in size 14, 15 . In addition, similar efforts identified large genome rearrangements such as those on nearly half of all human telomeres 16 .
Small-scale changes. Small-scale changes encompass all differences smaller than those identified by the largescale tests that have previously been discussed and that have a resolution limit of ~20 kb. These include single base pair changes, insertions and deletions (indels) of varying size and gene copy number differences. The differences can affect coding regions, non-coding regulatory regions and repetitive sequence content. Strategies for identifying small-scale changes often involve scanning the genome for signatures of positive selection when comparing humans with non-human primates and rodents. Although the results of these studies do not always coincide, there is a substantial overlap in the phenotypes implicated, including taste and olfaction, immunity, signal transduction, lipid metabolism, chaperone activity, motor activity and structural support 8, [17] [18] [19] [20] . However, it is likely that many important traits have yet to be identified given the large proportion of genes with no known function.
Initial estimates of sequence divergence between human and chimpanzee were ~1.2% 17 , a value based on the number of single-nucleotide substitution differences between the two genomes. However, these estimates did not account for unalignable regions between species that were due to structural divergences such as indels, highly duplicated sequences and CNVs. Although more recent divergence estimates reach as high as 5% when taking all types of variability into account 21 , high-confidence divergence estimates remain elusive. For example, the incompleteness of other primate genome assemblies impedes accurate assessment of the uniquely human indel content, for which estimates range from 0.21% to 3% 17, 22 . In addition, the importance of using multiple primate outgroups in making HLS assignments is borne out by recent studies of interspecific CNV. For example, these studies show a substantial number of genes with an increased copy number across the three African great apes 8, 23 , whereas the human copy number resembles that of orangutans and other primate lineages.
The first genome-wide and first gene-based array CGH study comparing humans to all four great ape lineages identified 140 genes with HLS changes (134 and 6 genes that showed HLS copy number gain and loss, respectively) 8 . Most of these HLS changes were confirmed after expanding the study to include ten primate lineages 10 . Interestingly, these HLS changes showed strong positional biases, frequently clustering in the genome at pericentromeric, subtelomeric and particularly complex duplication-rich regions. Indeed, the greatest number of HLS gene copy number
Box 2 | Accelerated evolution
There are a number of genomic regions that have undergone substantial alteration of sequence or rearrangement in the human lineage. Accelerated evolution refers to situations in which sequence changes occur at a rate greater than the neutral mutation rate. Accelerated evolution implies that the changes have been selected because of their advantageous nature and thus have undergone rapid fixation. Identification of these regions relies on multiple methods and differs depending on whether the change is at the coding sequence, non-coding sequence, copy number or other structural level.
At the protein-coding sequence level, a comparison of K a /K s values between sequences is often used, where K a is the number of nonsynonymous substitutions and K s is the number of synonymous substitutions. Most gene-coding regions will have K a /K s ratios well below 1.0 owing to the effects of purifying selection. By contrast, coding regions under positive selection will exhibit a higher frequency of nonsynonymous changes and, as a result, a higher K a /K s ratio. Through this method, studies have identified accelerated evolution in the human lineage of a number of genes, one example being genes involved in nervous system function 111 . However, these estimates can be confounded by gene conversion events that erase evidence of selection by creating stretches of identical nucleotide sequences between homologous genes 112 . Evaluation of non-coding sequences is not as straight forward because of the difficulty in interpreting the importance of a change. Thus, studies identifying regions of accelerated evolution in non-coding regions have relied on looking for humanspecific mutations in sequences that are highly conserved across mammals. An example of this is the identification of highly accelerated region 1 forward (HAR1F) 113 . HAR1F is a non-coding RNA expressed in the fetal brain that colocalizes with reelin, a protein that is important for cortical development.
Accelerated evolution may also occur at the level of whole genes or genomic regions in the form of copy number variations and structural rearrangements. Identification of such regions typically involves looking for HLS sequence copy number expansions and contractions that can range from as small as a few nucleotides to as large as segmental duplications identifiable by fluorescent in situ hybridization. Unlike the identification of accelerated evolution at the single-nucleotide level, there are no rigorous statistical tests for these types of changes, and they are mainly observational.
increases was found adjacent to the previously mentioned human-specific C bands on chromosomes 1 and 9 (REF. 8 ).
More recently, sequence read depth has been used to estimate copy number from next-generation sequencing (NGS) platforms, providing a complement to array-based strategies 24 . Although NGS has confirmed the findings of many previous interspecific array CGH studies 8 and identified new HLS candidates 25 , its wider use has been slowed by the short read-length capabilities of current NGS platforms (typical NGS read length is 50-150 bp). Short reads of highly duplicated sequences will often lack adjacent single copy sequences that serve to anchor the sequence read within the genome, making it difficult to localize duplicated copies accurately 26, 27 . Using NGS for sequencing regions containing structural variations (for example, highly similar duplicated sequences) has thus required the implementation of novel bioinformatics methods, delaying their broad use within the field 27 . For a full Review of the subjects, see REF. 26 .
Other major contributors to HLS genomic content are repetitive elements such as transposable element insertions, which constitute roughly half of the human genome. Transposable elements comprise both DNA transposons and retrotransposons, with retrotransposons subdivided into long terminal repeat (LTR)-containing and non-LTR elements. LTR-containing elements include endogenous retroviruses (ERVs), and recent hominid evolution has led to the accumulation of lineage-specific subsets of ERVs in great apes and humans 28 . Although non-LTRs, such as long interspersed element 1 (LINE-1; hereafter referred to as L1), Alu and hominid-specific SINE-VNTR-Alu composite repetitive (SVA) elements, encompass 75% of human repetitive content, it is difficult to determine what percentage of these are HLS owing to the incomplete nature of other primate genome sequence assemblies and their inability to accurately represent repetitive elements such as transposable elements 29 . Among those retrotransposons that have been successfully identified as HLS, the L1-Hs subfamily -the youngest of five HLS L1 subfamilies 30 -is of particular interest. At ~80-100 copies, L1-Hs insertions are the only transposable elements that are still active within the human genome 31 . L1-Hs elements are hypothesized to have a pivotal role in human neural plasticity as they are highly active during neurogenesis and contribute to neuron-specific genomic diversity 32, 33 . Taken together, these studies establish that there are far more genomic differences between human and other primate genomes than was originally thought 4 . Nevertheless, it is difficult to estimate precisely what fraction of the genome contains HLS sequences. Although the human genome is the most complete and accurate mammalian genome sequence currently available, it still contains many sequence gaps in complex genomic regions, which may harbour important HLS genes 34 . Confounded by the far more incomplete nature of all other primate genomes, there are likely to be many HLS changes that have yet to be discovered.
Box 3 | Human-lineage-specific changes at 1q21.1
Large cytogenetically visible changes in the genome structure were among the first human-specific genomic changes noted between humans and great apes. More recently, it has been determined that these regions harbour more importance than just being human-specific heterochromatin. Indeed, such regions are frequently adjacent to regions that are greatly enriched for evolutionarily recent gene duplications and that often function as gene nurseries 8, 10 . For example, the 1q21.1 region of the genome, which lies adjacent to the human-specific 1q12 C band and within the human-lineage-specific (HLS) chromosome 1 pericentric inversion, has undergone substantial genomic enlargement owing to numerous HLS copy number expansions within the region, as shown by the green bands in the figure. Numerous findings have identified the 1q21.1 region as being highly enriched for HLS copy number expansion, including: striking HLS copy number increases of DUF1220 protein domains (240 copies that map to 1q21.1 are shown by the red dots in the figure); copy number increases of the gene family that encodes them (namely, the neuroblastoma breakpoint family (NBPF)) 8 ; and duplicative transpositions of non-1q21.1 genes to the region, such as SLIT-ROBO Rho GTPase-activating protein 2 (SRGAP2) 71 and HYDIN
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. In addition, all of the above genes mentioned are candidates to explain both HLS neurodevelopmental changes and cognitive disorders 45, 46, 72, 96 . 
Domain amplification
Intragenic copy number increase of a protein domain (for example, in the DUF1220 domain).
Amino acid change
A DNA change that leads to a change at the protein sequence level (for example, in forkhead box P2 (FOXP2)).
Pseudogenization
Loss of gene function while most of the gene is retained (for example, in apolipoprotein C1 (APOC1)).
'Less-is-more' hypothesis
The hypothesis that gene loss has a major role in evolution.
Unique gene differences and associated traits
The number of identified HLS gene differences has rapidly increased in recent years, and this rate of discovery will probably continue in the future. Although there is a lag in the number of HLS phenotypes that have been associated with these HLS genomic changes, there is a substantial body of data attempting to link the two (see MOCA also includes the ability to link these genetic and genomic changes to many other features of human uniqueness, in domains ranging from molecules to culture
Alteration of gene structure resulting from splicing. Alteration of the gene structure provides a major mechanism through which evolutionarily adaptive changes can be introduced. A common means of modifying gene structure is through alterations in transcriptional splicing. Several studies have identified genes that are differentially spliced in the human lineage, including differential expression in the brain 35 and substantial numbers of genes involved in metabolism and morphological development 36 . A recent survey of human-specific transcript variants found 112 genes showing differential HLS transcripts as the result of novel promoters, exons and splicing sites, most of which are the result of transcriptional element insertions 37 . One of the best-characterized HLS transcripts is cholinergic receptor, muscarinic 3 (CHRM3), which encodes a G-protein-coupled receptor that mediates multiple physiological functions through its control of smooth muscle contraction 38 . In humans, an L1-Hs transposon insertion occurred at the 5ʹ end of the gene, resulting in a novel first exon, promoter and transcript 37, 38 . The L1-Hs-derived transcript is the only CHRM3 transcript expressed in the placenta and could be important for human gestation 38 . Alteration of gene structure by protein domain amplification. Gene structure can also be altered through changes in the number of protein domains in a gene. Although the importance of gene duplication to evolutionary change has been emphasized since 1970 (REF. 39 ), an appreciation for the contributions of protein domain amplification, the process by which a protein domain undergoes a copy number increase, has only recently emerged 40 .
The most striking example of this process has been reported for the DUF1220 protein domain, which shows the largest HLS copy number increase of any proteincoding region in the human genome 8, 41, 42 . DUF1220 domains are encoded within genes of the neuroblastoma breakpoint family (NBPF) 43, 44 , and although there are several HLS NBPF genes found in the human genome, the great majority of HLS copies of DUF1220 have arisen by intragenic domain hyper-amplification 42 .
With 272 copies, humans have more than twice the copy number of chimpanzees (which have 126 copies, the next highest number), whereas mice and rats have only one copy. It is estimated that, on average, 28 additional copies of DUF1220 domains have been added specifically to the human genome every million years since the human and Pan lineages diverged 42 . Recent correlative data from evolutionary studies and studies of brain size in normal and pathological populations (such as studies of individuals with microcephaly and macrocephaly) support the view that DUF1220 copy number is a general effector of brain size and may be largely responsible for the dramatic evolutionary expansion in brain size that occurred in the human lineage 45, 46 .
Alteration of gene structure by amino acid change. Gene structure can also be modified by smaller local alterations that result in changes to the amino acid sequence.
There are numerous examples of accelerated genome evolution that have been linked to amino acid change 19, 20 (BOX 2). One gene that may have ramifications for HLS metabolic changes is cytochrome c oxidase subunit Va (COX5A), the fifth of ten nuclear encoded subunits that make up the terminal proteins in the mitochondrial electron transport chain 47 . The genes encoding these subunits are generally highly conserved, but several show an increased rate of nonsynonymous substitutions in the anthropoid primate lineages, and COX5A contains two HLS amino acid changes 48 . Although a complete understanding of COX5A function is lacking, its interaction with thyroid hormone T2 suggests that the changes are important in regulating fat metabolism 49, 50 . A second example of a functionally important HLS amino acid change is provided by forkhead box P2 (FOXP2), which is proposed to have had an impact on human speech development 51 
Alteration of gene function by pseudogenization.
Not all gene alterations generate functional variants, and indeed such structural changes often produce nonfunctional genes. This is the case with pseudogenization, in which a sequence alteration renders the gene inactive, although most of the gene remains intact within the genome. A recent analysis using updated sequencing data found 38 fixed HLS pseudogenes in the human genome 52 , and only nine of these were fixed single copy genes. No excess of pseudogene fixation over expected rates was detected (that is, no evidence was found in support of Olson's 'less-is-more' hypothesis 53 ). One notable pseudogene is apolipoprotein C1 (APOC1), which is involved in lipoprotein metabolism 54 . Although great apes have two APOC1 genes, which encode negatively and positively charged forms of the protein, a premature stop codon in the gene that encodes the negatively charged protein resulted in humans who have only the positive APOC1 protein 55 . Although the implications of this loss are not currently understood, they may be related to human health. Human disease and mouse model studies indicate that polymorphisms in APOC1 are risk factors for more severe forms of Alzheimer's disease 56, 57 and for developing atherosclerosis and coronary heart disease 58, 59 . As these diseases appear to be unusually common and severe in humans, it is plausible that this gene loss could be a contributing factor 60, 61 . Other examples of confirmed pseudogenes are cytidine monophospho-N-acetylneuraminic acid hydroxyase (CMAH) and myosin heavy chain 16 (MYH16). Pseudogenization of CMAH was responsible for the inactivation of biosynthesis of the sialic acid N-glycolylneuraminic acid; this inactivation led to a radical reconfiguration of human cell surfaces by changing millions of molecules on the surface of human cells, bringing about major consequences for human-specific innate immunity and other systemic roles of sialic acid biology 62, 63 . A further example is the pseudogenization of a myosin filament, one of the basic units of muscle, which is specifically expressed in primate jaws and thus may have altered HLS craniofacial musculature and morphology 64 . Pseudogenization is also a common trend seen in HLS multigene families. This mechanism is often found in genes that code for proteins of neural sensation, such as those for olfaction. In the olfactory receptor family, more than 60% of the genes have been rendered nonfunctional by pseudogenization in the human lineage, although some increases in copy number have also been noted, specifically in the olfactory receptor, family 1, subfamily A, member 1 (OR1A1) gene 52 .
Alteration of gene function by gene conversion.
Many gene structural changes occur as the result of misalignments during replication. One such example of this is gene conversion, in which a portion of one gene is 'pasted' onto another gene and often occurs between members of genes within the same family. Although gene conversion events usually lead to pseudogenization, there are cases in which the conversion is functionally important. For example, sialic-acid-binding Ig superfamily lectin 11 (SIGLEC11), which encodes a member of a family of cell surface membrane proteins involved in modulating immunity, underwent two tandem HLS gene conversion events with an adjacent pseudogene, resulting in it acquiring a novel promoter and amino-terminal protein sequences 65 . This led to a change in the binding specificity of SIGLEC11, allowing recognition of novel ligands and initiation of its expression in microglia, the cells responsible for immune defence and neuroprotection in the central nervous system. SIGLEC11 expression alleviates neurotoxicity of microglial cells, and this can damage neurons and contribute to neurodegenerative disorders 66 . More recently, a unique expression pattern of SIGLEC11 and its ligands in human ovaries has demonstrated a possible role in HLS ovarian changes 67 .
Alteration of gene function by changes in gene family size. Gene family size can be altered through the addition of new copies of a gene that is already present in the lineage. Such duplicates, when functional, can simply confer an increase in dosage or can diverge to take on potentially new functions. The NBPF gene family encodes DUF1220 protein domains, as discussed above, which are thought to have a role in brain size and cognition 45, 46 . This family has undergone both HLS gene copy number expansion, adding an estimated four new human gene copies, and HLS domain copy number hyper-amplification, specifically adding more than 160 copies to the human genome 42 . Another HLS multigene family is the double homeobox (DUX) family, which includes a number of genes involved in transcriptional regulation and embryogenesis. In humans, three of the DUX genes on chromosome Y (DUXY2-4) have undergone neofunctionalization through the removal of an ancestral stop codon, although the functional importance of this mutation has yet to be determined 68 . Gene families also undergo inactivation events with relative frequency, although whole-gene deletion is generally rare. A recent example of this kind of loss is SIGLEC13 (REF. 69 ). The SIGLEC13 locus underwent an HLS whole-gene deletion mediated by an Alu recombination event 70 . Expression of the chimpanzee form of SIGLEC13 on monocytes affects inflammatory cytokine secretion and sialic acid binding, potentially enhancing susceptibility to infection by sialylated bacterial pathogens. It is hypothesized that SIGLEC13 loss may have been selected in relation to the bottleneck at the origin of modern humans, as it improved fitness in infants who would otherwise be susceptible to these bacteria 70 .
Copy number change. Although the previously mentioned DUF1220 domain sequences show an extreme HLS copy number increase, many additional HLS copy number changes exist and make up a substantial proportion of the differences between human and great ape genomes 8, 10, 25 . One example is SLIT-ROBO rho GTPase-activating protein 2 (SRGAP2), which has at least one fixed HLS partial duplication 25, 71 . SRGAP2 is a negative regulator of neuronal migration and promotes neurite outgrowth 72 . It is hypothesized that the partially duplicated protein dimerizes with the fulllength SRGAP2 protein, which acts as a dominant partial inhibitor and presumably leads to neotenous changes, including increased density of longer neurite spines 72 . Another identified HLS copy number increase involves aquaporin 7 (AQP7) 10 , of which there are several additional copies in the human genome. AQP7 is involved in the transport of water and glycerol and is responsible for use of glycerol (that is, energy) from fat cells, especially during fasting and prolonged human exercise 73, 74 . AQP7 amplification is hypothesized to be adaptive for metabolic needs in human endurance running and possibly thermoregulation by increased sweating 10, 75 . Such activities have been proposed to be crucial to humans' exceptional persistence-hunting capabilities and to the establishment of humans as diurnal endurance predators 10 .
Box 4 | Interpreting human-lineage-specific change
In spite of the substantial difficulties involved in determining the function of human-lineage-specific (HLS) genetic and genomic changes, a number of encouraging studies have been reported that may serve as models in this challenging arena. One example involved the use of humanized transgenic mice to show that a gain of function HLS-like phenotype was produced by amino acid change in forkhead box P2 (FOXP2) 51 . Evidence primarily based on mutations identified in a family with severe speech disabilities has implicated FOXP2 in human speech production 115 . Further analyses of the gene identified two HLS amino acid substitutions with evidence of positive selection 116, 117 . To investigate the phenotypic change resulting from the two amino acid differences, mice with humanized FOXP2 were generated 51 that showed increased neuronal dendritic length, increased synaptic plasticity and changes in ultrasonic vocalization. These results provide support that the two substitutions in this transcription factor could have affected human speech production capabilities.
Another example is the human accelerated conserved non-coding region 1 (HACNS1) enhancer. HACNS1 underwent accelerated evolution in the human lineage, as shown by a study using a series of expression assays in mouse embryos driven by the 546 bp homologous non-coding sequences from humans, chimpanzees and macaques 2 . The HACNS1 enhancer region from humans showed expression in the anterior developing forelimb and hindlimb, particularly in the forearm, the handplate, the anterior-most digit and the corresponding structures in the hindlimb (as shown in blue in the figure). Neither the chimpanzee nor the rhesus macaque constructs showed this pattern, suggesting that the region may have had an important role in HLS morphological changes to the hands and feet and making HACNS1 an important candidate for contributions to human bipedalism and tool making. Additional work on chimeric constructs then narrowed the expression pattern change to 13 divergent bases within an 80 bp region, establishing a narrow window for future investigations. 
Neofunctionalization
A process by which a genetic change in an allele produces a novel protein function (for example, in double homeobox (DUX) family members).
De novo human gene
A novel gene arising from formerly non-coding DNA (for example, in chronic lymphocytic leukaemia upregulated 1 (CLLU1)).
Human-specific disease
A disease that is present only in the human lineage. A number of diseases are thought to be human-specific (such as Alzheimer's disease and myocardial infarction), but proving that such diseases are not present in other species remains a challenging task.
The creation of de novo human genes. Although copy number change is established as a mechanism resulting in new gene function, it acts on pre-existing genes. By contrast, recent evidence suggests that several novel genes appeared in the human genome de novo from previously non-coding DNA. Although it was previously thought to be an extremely rare event in genome evolution, de novo human gene generation has become a subject of considerable interest and debate. Three published papers have claimed the identification of HLS de novo genes [76] [77] [78] . None has functional assignments, but this is not surprising given the novelty of the genes identified. However, one gene, chronic lymphocytic leukaemia upregulated 1 (CLLU1), is found to be upregulated in patients with a particularly aggressive form of chronic lymphocytic leukaemia 79 , lending credence to the claim that the regions identified are actually functional.
The HLS de novo gene publications are the subject of much controversy centred around two key issues. 
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; however, we will highlight a few examples. A 60.7 kb HLS deletion upstream of the androgen receptor (AR) gene was identified in a bioinformatics survey of regions that are highly conserved between chimpanzees and macaques; this deletion removed a regulatory region, leading to the loss of expression of AR in sensory vibrissae and penile spines 1 . Expression constructs in embryonic mice and in human foreskin fibroblasts showed that the corresponding non-deleted region from chimpanzees controls AR expression. Humans lack sensory vibrissae and penile spines, both of which are found in our closest ape relatives. Such anatomical differences between humans and the great apes lend additional support to the validity of these studies. Another example of a regulatory change is nucleotide changes in the human accelerated conserved non-coding region 1 (HACNS1) enhancer that may have led to HLS changes in digit and limb development 2 
Copy number changes may alter expression through gene dosage changes such as the duplication of protocadherin 11 X-linked (PCDH11X) onto the Y chromosome resulting in a Y-linked copy of the gene (namely, PCDH11Y) 81, 82 . This duplication doubled the gene dosage in humans, as genes present on both the X and Y chromosomes are protected from X-chromosome inactivation 83, 84 . This change is hypothesized to contribute to cerebral asymmetry and language development 84 , a claim that is corroborated by disease findings of severe language impairment associated with PCDH11X
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Other important examples of expression change are loss of SIGLEC5 expression from human T cells, plausibly resulting in T cell hyperactivation 86 , and uniquely human SIGLEC6 expression in the placenta 87 , which is hypothesized to be implicated in the human-specific disease pre-eclampsia 88 . The specific genomic alterations that are responsible for these expression changes remain unknown.
HLS changes linked with human disease
Human disease has been, and continues to be, one of the few ways of highlighting the phenotypic implications of many HLS genetic changes 51 . Although the link
Box 5 | The Matrix of Comparative Anthropogeny
The Matrix of Comparative Anthropogeny (MOCA) of the Center for Academic Training and Research in Anthropogeny is a Web-based collection of information comparing humans and our closest evolutionary relatives (namely, chimpanzees, bonobos, gorillas and orangutans -the 'great apes') that has a specific emphasis on uniquely human features. Comparisons of these non-human hominids with humans are difficult, as so little is currently known about their phenotypic features ('phenomes') in contrast to humans 30 . Ethical, fiscal and practical issues also limit the collection of further information about the great apes. MOCA attempts to collect existing information about human-lineage-specific differences from great apes that is currently scattered in the literature. Having such information in one location could lead to new insights and multi-disciplinary interactions, as well as to ethically sound studies that could explain these differences and improve our understanding of uniquely human specializations. It is for this reason that MOCA is called a 'matrix': an arrangement of information from which something else originates, develops or takes form. MOCA is organized by domains, each of which groups topics by areas of interest and scientific discipline. MOCA is a work in progress, and each topic entry will eventually cover existing information about a particular difference (either alleged or documented) between humans and non-human hominids. Topics are also linked across domains: for example, each genetic human-lineage-specific topic is linked to phenotypic traits, including anatomy, physiology, behaviour and even culture to the extent that this is possible. MOCA is not targeted at experts in specific disciplines but rather aims to communicate basic information to a broad audience of scientists from many backgrounds and to the interested lay public. MOCA includes not only aspects wherein there are known or apparent differences between humans and great apes, but additionally topics for which popular wisdom about claimed or assumed differences is not entirely correct.
The MOCA site is being launched at an early stage so that interested readers with expertise on specific topics can provide feedback. New information and topics will continue to be added as they are identified or discovered.
Gene nurseries
Dynamic regions of the genome that are capable of undergoing rapid evolutionary change owing to a duplication-prone genome architecture and are therefore frequent sites for the production of novel genes by gene duplication.
Hydatidiform mole
An abnormal form of pregnancy in which a non-viable egg, probably the result of an egg missing a nucleus, is fertilized and becomes a mass on the uterine wall. The resultant growing tissue is haploid in nature owing to it having only a paternal genetic contribution.
between human disease and HLS genomic changes has been the subject of recent reviews 4, 89 , an appreciation of this connection has begun to emerge only in the past decade 90 . Demonstration of causality versus association is difficult, but it is increasingly clear that many regions undergoing HLS change have an important role in human disease
. Selection on numerous genes involved in innate immunity improved human resistance to particular diseases but apparently did so at the cost of other human-specific impairments, such as an increased propensity for autoimmune disorders, including atopic diseases and allergies 91 . Increased immune response may have arisen during the unique changes to HLS pathogen regimes associated with use of home bases, scavenging or hunting of different prey and more extensive intergroup contacts. An example of association between improved immunity and autoimmune disorders is seen in the case of the SIGLEC gene family. The levels of many SIGLEC genes are decreased in humans; as most of these have an inhibitory effect on lymphocyte activation, lower SIGLEC expression leads to increased lymphocyte reactivity 63, 92 . This hyper-reactivity, although potentially protective against infection, may predispose to autoimmunity. In addition, a number of HLS changes linked to human-specific cognitive abilities are associated with the severity of Alzheimer's disease and dementias 56, 93 . For example, FLJ33706 (REF. 77 ) -a novel human gene that is highly expressed in the cortex, cerebellum and midbrain -has been reported to show increased expression in Alzheimer's brain specimens. The asp (abnormal spindle) homologue, microcephaly-associated (ASPM) gene 94, 95 reportedly underwent accelerated evolution in the human lineage, although the certainty of this is contested in recent literature 96 . Thus there are multiple cases in which a region that was found to have undergone HLS selection is also associated with one or more major disease phenotypes.
Beyond natural selection, unstable genomic architecture is another driving force in human genetic novelty associated with human disease. Certain regions of the genome that are complex and repeat-rich often act as gene nurseries 8, 10 and might therefore be evolutionarily advantageous to maintain in the population. However, the instability associated with the architectures of the same genomic regions also makes them prone to deleterious copy number gains and losses. Such regions have been linked to numerous genomic disorders, including several neuropsychiatric and neurodevelopmental diseases 97, 98 
. For example, the 1q21.1 region of the human genome has undergone multiple HLS expansions, including those involving the aforementioned DUF1220 protein domain 8, 42 and SRGAP2 (REF. 71 ), two candidates that could be involved in human brain morphological changes. CNVs in the region have also been implicated in a striking number of recurrent diseases 45, 46 . Therefore, as the study of disease continues to be a resource for understanding the function of HLS genomic change, the identification of HLS changes provides a source of candidate genetic changes contributing to human disease.
Conclusions and prospects
With continued improvements in DNA-sequencing technologies 99 , the number of new genome sequences available will probably continue to grow exponentially, and this can be expected to clarify further which changes are truly HLS. However, unless there is a focus on developing technologies to accurately sequence and to assemble complex, duplication-rich genomic regions, such regions will continue to be woefully under-examined. For example, the last two great apes to be sequenced, bonobos and gorillas, were both sequenced using whole-genome shotgun methods that relied heavily on NGS technologies 100, 101 . These methods generated poor coverage and assembly of duplication-rich regions and therefore are deficient in sequences that are particularly relevant to the identification of genes showing HLS changes in copy number 102 . Obtaining accurate sequence from complex genomic regions is important for several reasons: they have been linked to numerous diseases and disorders 24, 90 ; they are often sites of rapid evolutionary change 8 ; and they have been proposed as candidates to harbour the 'missing genetic heritability' that has eluded many genome-wide disease gene investigations 34 . Finally, the importance of examining complex genomic regions has been recently borne out by a study of the human-specific SRGAP2 gene duplications. These extra copies were discovered only through the development of a new genome assembly that used a haploid human genome resource (namely, hydatidiform mole) and long-read sequencing to accurately sequence repetitive content 71 . Another area of improvement needed is exemplified in de novo sequencing efforts [76] [77] [78] . The inability to verify the results of prior studies owing to differences between genome builds only epitomizes the need for solid manual annotation of genes in all genomes. Inconsistencies in the annotation of the human genome -which has the most extensive annotation work of all of the mammalian genomes -can lead to reduced confidence in gene calls in other primate genomes. Conclusive identification of a gene's HLS status requires the availability of accurate genome assemblies from multiple individuals in a lineage combined with comparison to multiple individuals in multiple primate outgroups.
Despite the difficulties involved, it is reasonable to expect that the process of linking human-specific gene and genomic features to important human-specific traits will accelerate over the next several years. However, challenges in the field continue, such as the limited data existing on great ape phenotypes compared with human phenotypes 103 and the major impact of geneculture interactions in generating the human phenotype 10 . While keeping ethical considerations foremost in mind, it is important to gather as much novel information on the phenotypes of these species as possible; this objective would be much advanced by providing proper medical care to captive great apes in the United States and in ape sanctuaries throughout Africa 104 . Improving transgenic technology in mice potentially affords more functional insights than disease associations alone and as such may prove to be a valuable strategy for verifying many HLS traits.
It may be anticipated that the identification of key genes and genomic sequences that are responsible for the unusual capacities of human cognition and physiology may lay the groundwork for new fields of study. For example, a new field of neuroscience, evolutionary neurogenomics, may emerge from the application of genomic technologies to the study of human brain evolution 4 . By providing a novel, biologically unbiased entry point for the study of the brain, such a discipline may uncover new insights regarding human cognitive function and dysfunction
. Many of the genetic changes underlying the dramatic change in cognitive capacities in the human lineage are likely to be a part of evolutionary trade-offs, where increased mental capacities have come at a cost to other organismal functions. Thus, genotype-to-phenotype associations are likely to have medical relevance as well, showing how evolutionary selective pressures may have produced side effects, such as unstable genomic regions enriched for disease-associated variants (for example, 1q21 and 5q13) 8, 45, 46, 102, 105 . Finally, we can anticipate that using genome-based data to help decipher what has made the human species unique will become an increasingly powerful tool for understanding our evolutionary origins (that is, our anthropogeny) and the human condition.
